M. A. El-Shorbagy | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Prof. M. A. El-Shorbagy | Cell Structure Analysis | Best Researcher Award

Prof. M. A. El-Shorbagy, Prince Sattam Bin Abdulaziz University, Saudi Arabia

Prof. Mohammed Abd El-Rahman El-Shorbagy Hassan is a distinguished academic specializing in engineering mathematics and optimization. Born in Egypt on March 4, 1982, he currently serves as a Professor in the Department of Mathematics at the College of Science and Humanities Studies, Prince Sattam Bin Abdulaziz University, Saudi Arabia. With a career spanning over a decade in higher education and applied research, Prof. El-Shorbagy has contributed significantly to the fields of numerical optimization, artificial intelligence, and multiobjective programming. He is widely published and recognized for his scholarly books and high-impact journal articles. His work integrates mathematical rigor with real-world engineering applications. In addition to teaching and mentoring, he actively participates in international conferences and collaborative research projects. Known for his hybrid approaches combining swarm intelligence with classical methods, Prof. El-Shorbagy stands as a prominent figure in optimization and computational engineering.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Extensive Research Output:
    Prof. El-Shorbagy has a substantial publication record that includes books, high-impact journal articles, and international conference proceedings. His research appears in prestigious outlets such as Scientific Reports, Renewable Energy, and Materials, with multiple papers exceeding 100 citations.

  2. Strong Interdisciplinary Focus:
    His work bridges mathematics, artificial intelligence, and engineering, showcasing versatility. He effectively combines theoretical frameworks (e.g., optimization theory) with practical applications in power systems, materials science, and fluid dynamics.

  3. Innovative Methodologies:
    Known for hybridizing Particle Swarm Optimization, Genetic Algorithms, and Trust Region methods, he has demonstrated an innovative approach to solving complex, real-world optimization problems.

  4. Global Academic Impact:
    His presence in international conferences across Egypt, France, and Saudi Arabia highlights his global engagement. His work on swarm intelligence and nanofluid modeling reflects both theoretical significance and technological relevance.

  5. Authorship of Academic Books:
    Author of three technical books with Lambert Academic Publishing, which extend his research to a broader academic audience, enhancing educational and professional value.

⚠️ Areas for Improvement:

  1. Greater Industry Collaboration:
    While his academic output is exceptional, engaging in more industry-linked projects (e.g., smart grids, AI in civil infrastructure) could boost the applied relevance of his work.

  2. Editorial and Review Roles:
    Taking on editorial positions in leading journals or acting as a regular peer reviewer could enhance his visibility and influence in the academic publishing landscape.

  3. Funding and Grants:
    Participation in or leadership of internationally funded research programs (such as Horizon Europe or NSF collaborations) would strengthen his research infrastructure and international profile.

🎓 Education:

Prof. El-Shorbagy earned his Ph.D. in Engineering Mathematics from the Department of Basic Engineering Science, Faculty of Engineering, Menoufia University, Egypt, in July 2013. His doctoral thesis, “A Study of Some Numerical Optimization Methods to Solve Multiobjective Mathematical Programming Problems”, focused on advanced optimization algorithms. Prior to this, he completed his M.Sc. in February 2010 at the same institution, where he presented a thesis titled “Hybrid Particle Swarm Optimization Algorithm for Multiobjective Optimization”. Both degrees reflect his specialization and depth in engineering mathematics with emphasis on numerical methods and artificial intelligence. Throughout his academic formation, he was mentored by prominent researchers in the fields of computational mathematics and optimization. His educational background has laid a solid foundation for his subsequent contributions to academia, allowing him to merge theoretical principles with cutting-edge applications in engineering and data-driven modeling.

🧑‍🏫 Experience:

Prof. El-Shorbagy has amassed over 15 years of academic and research experience. He currently holds the position of Professor in the Department of Mathematics, College of Science and Humanities Studies, at Prince Sattam Bin Abdulaziz University in Saudi Arabia. His career began in Egypt, where he contributed to both teaching and research at Menoufia University. Over the years, he has developed and delivered undergraduate and postgraduate courses in mathematics, optimization techniques, numerical methods, and computational intelligence. In parallel, he has maintained an active research agenda, collaborating with global institutions and publishing extensively in top-tier journals. He is well-versed in supervising theses and projects related to AI-based optimization methods and engineering simulations. Prof. El-Shorbagy is also a frequent speaker at international conferences and has been part of organizing committees, reviewer boards, and technical panels—proving his leadership in academic and scientific communities.

🔬 Research Focus:

Prof. El-Shorbagy’s research revolves around optimization theory and its practical application to engineering and mathematical models. His primary focus is on developing and enhancing numerical methods for solving multiobjective optimization problems using artificial intelligence. Key techniques in his portfolio include Particle Swarm Optimization (PSO), Genetic Algorithms (GA), Trust-Region Methods, and hybrid models that integrate local search strategies. Recently, he has extended his expertise to smart materials, nanofluids, energy optimization, and AI-driven modeling in civil and mechanical engineering systems. His interdisciplinary approach bridges theory and practice, using computational models to solve complex real-world problems such as wind turbine placement, reactive power compensation, and fluid dynamics. Prof. El-Shorbagy’s research is not only high in theoretical impact but also has broad industrial and environmental relevance, making him a valuable contributor to applied sciences and engineering optimization domains.

📰 Publications Top Notes:

  • 🧬 Integrating PSO with GA for Solving Nonlinear Optimization Problems, JCAM, 2011

  • 🐝 Local Search-Based Hybrid PSO for Multiobjective Optimization, Swarm & Evolutionary Computation, 2012

  • 💧 Darcy Ternary-Hybrid Nanofluid Flow with Induction Effects, Micromachines, 2022

  • ⚗️ Green Synthesis of ZnO–CuO Nanoparticles and Cytotoxicity, Scientific Reports, 2021

  • 🧱 Glass Fiber-Reinforced Concrete: Mechanical and Microstructure Analysis, Materials, 2022

  • 🌬️ Optimization of Wind Turbines Siting Using GA-Based Local Search, Renewable Energy, 2018

  • 🔥 Hybrid Nanofluid Flow with Hall Current and Chemical Reaction, Alexandria Eng. Journal, 2022

  • 🌴 Coconut Fiber Reinforced Concrete: State-of-the-Art Review, Materials, 2022

  • ⚡ MHD Stagnation Point Flow with Joule Heating and Convective Effects, Case Studies in Thermal Eng., 2021

  • ♻️ Concrete with Waste Glass and Recycled Aggregate Substitution, Materials, 2022

🧾 Conclusion:

Prof. Mohammed Abd El-Rahman El-Shorbagy Hassan is a highly suitable candidate for the Best Researcher Award. His consistent and high-quality contributions to engineering mathematics and optimization, impactful publication record, and innovative research approaches mark him as a leading scholar in his domain. By expanding his engagement with industry and international grant opportunities, he could further elevate his already outstanding academic profile. He exemplifies the blend of research excellence, innovation, and practical relevance that such an award seeks to recognize.

Dalia Saleh | Cancer Cell Biology | Innovative Research Award

Published on by Cell Biologist

Prof . Dalia Saleh | Cancer Cell Biology | Innovative Research Award

Prof . Dalia Saleh | National Research Centre | Egypt

Dr. Dalia Osama Abd El Fattah Saleh is a distinguished pharmacologist with over two decades of experience in experimental pharmacology and drug development. She holds a Ph.D. in Pharmacology from Cairo University and currently serves as a Professor at the National Research Centre in Cairo, Egypt. Dr. Saleh has contributed to numerous high-impact scientific journals and has led pioneering work in the areas of metabolic disorders, drug safety, and vascular pharmacology. Her multidisciplinary collaborations and continuous professional development from institutions like King’s College London demonstrate her dedication to excellence in research and education. She is also recognized for her commitment to academic instruction and quality assurance, having served as a Quality Assurance Director. Her work bridges scientific discovery and real-world therapeutic applications, making her a strong candidate for innovation-focused research awards.

publication profile:

scopus

Strengths for the Award:

  1. Robust Academic Background:
    Dr. Saleh holds a Ph.D. in Pharmacology from Cairo University and has a long-standing academic and research career in pharmacology and drug development. Her doctoral and master’s theses reflect a strong foundation in vascular pharmacology, metabolic disorders, and endocrine influence—fields of enduring relevance.

  2. Consistent Research Productivity:
    Her recent publication record (2022–2024) is prolific and impactful, with studies published in high-visibility journals such as Scientific Reports, Biochemistry and Cell Biology, Naunyn-Schmiedeberg’s Archives of Pharmacology, and Environmental Science and Pollution Research. Her work covers cutting-edge pharmacological topics, including:

    • AMPK/mTOR signaling pathways,

    • Neuroprotection and anti-inflammatory mechanisms,

    • Herbal and synthetic compounds in disease modulation,

    • Hepatic encephalopathy, diabetic nephropathy, and cystitis models.

  3. Interdisciplinary and Translational Approach:
    Dr. Saleh bridges basic pharmacological research with clinical relevance. Her investigations into molecular pathways (e.g., NF-κB, PI3K/Akt, SIRT-1) are grounded in disease models, thus demonstrating translational potential. Her inclusion of both natural and synthetic agents further adds diversity and innovation to her research.

  4. Capacity Building and International Exposure:
    She has participated in Continuing Professional Development modules at King’s College London, emphasizing drug safety, statistics, and ethics—key areas in modern drug development. This international engagement underscores her commitment to staying updated and aligned with global standards.

  5. Institutional Contribution and Leadership:
    As a Professor and former Quality Assurance Director at the National Research Centre (NRC), she has contributed to institutional excellence, including achieving ISO 9001/2008 certification. These roles reflect her leadership, organizational, and strategic planning skills.

Areas for Improvement:

  1. Principal Investigator Leadership:
    While her name appears consistently in multi-author studies, further highlighting her role as the principal investigator (PI) or corresponding author could strengthen her case for innovation leadership.

  2. Patents or Product Development:
    There is no mention of patents or direct product development based on her findings. Translating research into tangible therapeutics or clinical trials would significantly elevate her eligibility for innovation-specific awards.

  3. Global Collaborations and Grants:
    Although she has participated in international seminars, active global collaborations or leading major international grants/projects would further establish her as a global innovator.

  4. Public/Industry Impact:
    While the academic impact is strong, showcasing industry partnerships or policy-level influence (e.g., contributions to clinical guidelines or regulatory science) would align more directly with innovation awards that emphasize practical application.

🎓 Education Summary :

Dr. Dalia Saleh completed her higher education at Cairo University’s Faculty of Pharmacy, where she earned her Master of Science in Pharmacology in 2009 and Doctor of Philosophy in Pharmacology in 2012. Her M.Sc. thesis focused on the vascular and biochemical effects of rosiglitazone in diabetic rats, reflecting early interests in metabolic pharmacology. Her Ph.D. expanded on this foundation by exploring estrogen’s potential role in managing vascular changes related to insulin resistance. Both theses demonstrated robust experimental designs and contributed new insights into the interplay between hormonal and metabolic pathways in disease models. Dr. Saleh has since built on this academic background with advanced training in clinical drug development, safety, and biostatistics at King’s College London in 2023, indicating a continued commitment to integrating modern pharmaceutical science and translational research into her academic portfolio. This rich educational foundation underpins her success as a researcher and educator.

🔬 Research Focus :

Dr. Saleh’s research focuses on experimental pharmacology, with a special interest in metabolic diseases, drug-induced toxicities, inflammation, and vascular pharmacology. Her studies frequently involve animal models to investigate the mechanisms of drug action and to evaluate the protective or therapeutic roles of natural products and synthetic compounds. A recurring theme in her work is exploring the modulation of signaling pathways like AMPK, NF-κB, PI3K/mTOR, and Nrf2 in the context of oxidative stress, inflammation, and cellular apoptosis. She has also studied the role of hormonal influences in disease models, such as estrogen’s effect on insulin resistance. Her research employs modern analytical techniques and integrates molecular biology with pharmacodynamics to derive mechanistic insights. This strong focus on mechanistic pharmacology enhances her work’s relevance in drug development, particularly for conditions such as diabetic complications, hepatic encephalopathy, nephropathy, and chemotherapy-induced toxicities.

📚 Publications Top Note:

  1. 🧪 Eugenol alleviates acrylamide-induced testicular toxicity via AMPK/pAKT/mTOR modulation – Scientific Reports, 2024

  2. 🧠 Trimetazidine prevents cisplatin neuropathy through AMPK, Nrf2, and NF-κB pathways – Biochemistry and Cell Biology, 2023

  3. 🔬 Novel chromone-thiazolopyrimidines as TNF-α, IL-6, and PGE2 inhibitors – Polycyclic Aromatic Compounds, 2023

  4. 🚽 Chrysin protects against cyclophosphamide-induced hemorrhagic cystitis via anti-inflammatory signaling – Chemico-Biological Interactions, 2023

  5. 🧃 Linagliptin & L-arginine synergy in gastric hyperacidity via EP4 receptor upregulation – Naunyn-Schmiedeberg’s Archives of Pharmacology, 2023

  6. 🧠 L-arginine reduces thioacetamide-induced hepatic encephalopathy via NF-κB downregulation – Environmental Science and Pollution Research, 2023

  7. 🌿 Calotropis procera seed oil shows anti-inflammatory and antiparasitic activity – Arabian Journal of Chemistry, 2022

  8. 🛡️ Olmesartan mitigates diabetic nephropathy via AGE/PKC and TLR4/SIRT-1 pathways – European Journal of Pharmacology, 2022

  9. 🍃 Plumbago species show anti-fibrotic effects in liver fibrosis rat models – Scientific Reports, 2022

  10. 🫀 Omega-3 combats doxorubicin-induced liver toxicity via Nrf2/PI3K/Akt signaling – Pending Publication

Conclusion:

Dr. Dalia O. Saleh presents a strong candidacy for the Research for Innovative Research Award, particularly due to her sustained publication record, mechanistic depth in pharmacology, and commitment to professional development and institutional excellence. Her work spans innovative mechanistic explorations and novel therapeutic evaluations, showing real promise in addressing current pharmacological challenges.

illych alvarez | Cell-Cell Communication | Best Researcher Award

Published on by Cell Biologist

Dr. illych alvarez | Cell-Cell Communication | Best Researcher Award

Dr. illych alvarez, Escuela superior Politecnica del litoral, Ecuador

Illych Ramses Alvarez Alvarez is a mathematician, professor, and researcher from Guayaquil, Ecuador, specializing in chaos theory, artificial intelligence, and applied mathematics. With a rich background in academia and educational innovation, he has played a vital role in advancing active learning in mathematics at the Escuela Superior Politécnica del Litoral (ESPOL), where he currently teaches and conducts research. He has also taught at the Polytechnic University of Valencia, Spain. Dr. Alvarez is widely published in prestigious journals, focusing on dynamic systems, fuzzy logic, numerical simulations, and biomedical modeling. His work bridges complex theoretical concepts and practical applications in areas such as diabetes treatment, heat transfer, and mortality analysis. An active contributor to scientific communities, he is a frequent keynote speaker, reviewer, and track chair at international conferences including LACCEI. His dedication to cross-disciplinary collaboration and mathematical education makes him a prominent figure in Latin American scientific research.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. 🌍 International Academic Recognition
    Dr. Alvarez holds advanced degrees from respected institutions in Spain, Cuba, and Ecuador, and teaches both locally and abroad (ESPOL and Polytechnic University of Valencia).

  2. 🔬 Interdisciplinary Research Impact
    His research bridges pure and applied mathematics, with contributions to fields like biomedical engineering (e.g., insulin delivery), materials science, control systems, and fuzzy logic.

  3. 📚 High-Quality and Diverse Publications
    With numerous peer-reviewed journal articles and conference papers indexed in Scopus and published in reputable outlets (Elsevier, Springer, Wiley), his academic output is substantial and impactful.

  4. 🎤 Active Role in Academic Community
    He has served as a keynote speaker, reviewer, committee member, and research track chair at major international events like LACCEI, REDU, and ICCSCM.

  5. 📈 Innovation in Education
    A recognized innovator in teaching methodologies, he led the design of active learning strategies and B-learning models, demonstrating a commitment to educational reform.

  6. 🔎 Societal Relevance of Research
    His work includes applied studies in child mortality analysis and educational equity, aligning mathematical research with real-world social impact.

⚠️ Areas for Improvement:

  • 🌐 Expand Global Collaborations
    While active in Latin America and Europe, broader partnerships across Asia or North America could elevate the visibility and global reach of his work.

  • 📢 Enhanced Science Communication
    More engagement with popular science outlets, policy forums, or public-facing platforms would help communicate his research to non-specialist audiences and stakeholders.

  • 🎯 Focused Thematic Consolidation
    Given the wide range of topics, a deeper focus or a flagship research theme could enhance long-term branding and scholarly identity.

🎓 Education:

Illych Alvarez holds a Ph.D. in Mathematics from the Polytechnic University of Valencia in Spain, where he explored advanced topics in dynamical systems and mathematical modeling. His academic journey also includes a Master’s in Mathematical Sciences with a focus on Numerical Mathematics from the University of Havana, Cuba. Additionally, he earned a Master’s in Mathematics Teaching from the Escuela Superior Politécnica del Litoral (ESPOL) in Ecuador, underscoring his commitment to mathematics education. Complementing his technical expertise is a Bachelor’s degree in Education Sciences from Universidad Metropolitana del Ecuador, which equipped him with pedagogical tools for effective teaching. This combination of theoretical depth, computational skills, and instructional knowledge enables Dr. Alvarez to operate at the intersection of education and scientific innovation. His educational path reflects both a local and global perspective on mathematics, fostering a blend of research rigor and educational leadership.

💼 Experience:

Dr. Illych Alvarez’s professional journey spans over two decades, blending teaching, research, and academic leadership. He began his career in secondary education, serving as Head of Mathematics and Academic Coordinator at renowned institutions such as Liceo Naval de Guayaquil and Liceo Los Andes. Transitioning to higher education, he became a key figure at ESPOL, where he serves as Professor and Researcher, curriculum designer, and workshop instructor. At ESPOL, he led the Active Learning Mathematics Program and has taught foundational and advanced mathematics courses. His international experience includes teaching at the Polytechnic University of Valencia. Dr. Alvarez has also made his mark in global academic communities, contributing as a keynote speaker, scientific reviewer, and track chair at numerous conferences including LACCEI. His combined experience in both grassroots education and advanced research positions him as a comprehensive academic leader committed to both knowledge generation and knowledge dissemination.

🔬 Research Focus:

Dr. Illych Alvarez’s research spans dynamical systems, chaos theory, numerical simulations, and artificial intelligence, with an emphasis on applied mathematics. His work explores complex phenomena in set-valued and fuzzy dynamical systems, often integrating numerical methods to visualize abstract mathematical behavior. A unique dimension of his research is its interdisciplinary application—his recent studies include numerical modeling of chemo-fluidic oscillators for diabetes treatment, showcasing the practical reach of theoretical mathematics. He also investigates recurrence and transitivity in dynamic environments and applies control theory to epidemiological and demographic models. Furthermore, his interest in mathematics education has led him to develop and assess innovative B-learning and inverted classroom methodologies. This dual focus on theoretical rigor and pedagogical innovation distinguishes his contributions to both science and society. Dr. Alvarez’s research continues to evolve toward multiscale modeling and computational methods, making significant strides in both academic and applied contexts.

📚 Publications Top Notes:

  • 📘 Advanced Numerical Modeling and Simulation of Hydrogel‐Based Chemo Fluidic Oscillator for Enhanced Insulin Delivery System in Diabetes Treatment

  • 📘 Recurrence in Collective Dynamics: From the Hyperspace to Fuzzy Dynamical Systems

  • 📘 Advanced Extensions and Applications of Transitivity and Mixing in Set‐Valued Dynamics With Numerical Simulations and Visual Insights

  • 📘 Advanced Extensions and Applications of Transitivity and Mixing in Set-Valued Dynamics with Numerical Simulations and Visual Insights (SSRN)

  • 📘 Heat Transfer Problem Solving Techniques in Materials Engineering: A Numerical Approach and Practical Applications

  • 📘 Recurrence in Collective Dynamics: From the Hyperspace to Fuzzy Dynamical Systems (arXiv)

  • 📘 Advanced Numerical Analysis and Simulation of a Chemo-Fluidic Oscillator: Comparative Study of Numerical Methods and Robustness Evaluation

  • 📘 A New B-Learning Methodology for Teaching Differential Integral Calculus in a School of Engineering

  • 📘 Optimal Exponentially Weighted Moving Average Of T² Chart

  • 📘 A New Inverted Class Methodology Applied as a Pilot Program to Students Aspiring to Enter an Ecuadorian University

  • 📘 Application of Control Charts to Detect Anomalies in Child Mortality in Ecuador

📝 Conclusion:

Illych Ramses Alvarez Alvarez demonstrates excellence in both research and education, with a dynamic profile that integrates theoretical innovation, real-world application, and pedagogical leadership. His impactful publications, international engagement, and interdisciplinary expertise make him a highly suitable and competitive candidate for the Best Researcher Award. His work exemplifies the integration of mathematics with societal needs and educational advancement, aligning perfectly with the core values of academic excellence and innovation.

Assoc. Prof. Dr Amal Zaher | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr Amal Zaher | Microbial Cell Biology | Best Researcher Award

Assoc. Prof. Dr Amal Zaher | Beni-suef University | Egypt

Dr. Amal Zaher Shehata Mohamad is a distinguished researcher in the field of Microbial Cell Biology, affiliated with the Faculty of Postgraduate Studies for Advanced Sciences at Beni-Suef University, Egypt. Her research primarily focuses on sustainable energy solutions, environmental remediation, and the application of nanomaterials in biotechnological processes. Dr. Shehata has co-authored several impactful publications, including studies on the repurposing of Co-Fe LDH and Co-Fe LDH/cellulose micro-adsorbents for sustainable energy generation in direct methanol fuel cells. Her work has been recognized for its innovative approach to recycling waste materials into high-value applications, contributing significantly to the advancement of green technologies

Publication Profile:

scopus

ocrid

Summary of Suitability for Best Researcher Award:

Dr. Amal Zaher Shehata Mohamad is a seasoned and highly productive researcher in the fields of microbial cell biology, nanomaterials, wastewater treatment, and environmental remediation. Her multidisciplinary research intersects applied chemistry, sustainable environmental practices, and biotechnology, making substantial contributions to both academic knowledge and societal needs.

Her publication record is impressive, with dozens of peer-reviewed journal articles, book chapters, and conference presentations in internationally indexed outlets such as Scientific Reports, Environmental Science and Pollution Research, Nanomaterials, and Journal of Molecular Liquids. These works highlight her proficiency in synthesizing and characterizing advanced nanomaterials, particularly layered double hydroxides (LDHs), metal-organic frameworks (MOFs), and electrocatalysts, applied to energy generation and water purification.

Dr. Zaher has repeatedly demonstrated an ability to address real-world environmental challenges through academic rigor. Her investigations into antibiotic and heavy metal removal, green synthesis techniques, and renewable energy solutions underline a commitment to sustainable development goals (SDGs).

She is also a collaborator on various multidisciplinary projects, working alongside chemists, biotechnologists, and engineers, indicating strong team science experience. Furthermore, she has contributed to the academic development of her institution and country through teaching, mentoring, and scholarly engagement.

Education :

Dr. Shehata completed her undergraduate studies at Minia University, Egypt, where she earned her Bachelor’s degree in a relevant field. She further pursued her academic ambitions by obtaining a Master’s degree, followed by a Ph.D. in a specialized area of Microbial Cell Biology. Her doctoral research focused on the application of nanomaterials in environmental and energy-related biotechnological processes. Throughout her academic journey, Dr. Shehata has demonstrated a strong commitment to scientific excellence and innovation, which is evident in her extensive publication record and contributions to the field.

Research Skills :

Dr. Shehata possesses a diverse skill set in microbial cell biology and environmental biotechnology. Her research expertise includes the synthesis and characterization of nanomaterials, particularly Co-Fe LDH and Co-Fe LDH/cellulose composites, for applications in environmental remediation and energy generation. She is proficient in various analytical techniques such as FT-IR, XRD, SEM, TEM, TGA, and zeta potential analyses, which she employs to assess the properties and effectiveness of synthesized materials. Furthermore, Dr. Shehata has experience in designing and conducting experiments to evaluate the adsorption capacities and catalytic activities of these materials, contributing to the development of sustainable solutions for wastewater treatment and energy production. Her interdisciplinary approach and technical proficiency make her a valuable asset to the field of microbial cell biology

Publications Top Note:

  • 📘 Nanomaterials for Electrochemical Sensing of Heavy Metals in Wastewater Streams

    • Book: Handbook of Nanosensors

    • Authors: Rehab Mahmoud, E. E. Abdel-Hady, Hamdy F. M. Mohammed, Mohamed Ibrahim, Gehad Abd El-Fatah, Amal Zaher, Yasser Gadelhak

    • Year: 2024

  • 🧪 Iron-trimesic metal organic frameworks as nano-adsorbents for tetracycline and Ceftriaxone contaminated wastewater effluents

    • Journal: Egyptian Journal of Chemistry

    • Authors: Amal Zaher, Hossam Nassar, Alzahraa Shaban, Taha Abdelmonein, Esaraa Salama, Yasser Gaber, Nabila Shehata, Reda Abdelhameed, Rehab Mahmoud

    • Year: 2022

  • 🏭 Application of Quality Control Tools in Carpet Industry: A Case Study

    • Journal: Trends in Sciences

    • Authors: Amal Zaher, Said Ahmed, Hamada Mohamed, Abdel Hakeem EL Minhawy

    • Year: 2022

  • 🦠 Antibacterial activities of layer double hydroxide nanocubes based on Zeolite templates

    • Journal: Egyptian Journal of Chemistry

    • Author: Amal Zaher

    • Year: 2022

  • 🧲 LDH nanocubes synthesized with zeolite templates and their high performance as adsorbents

    • Journal: Nanomaterials

    • Authors: Elkartehi M.E., Mahmoud R., Shehata N., Farghali A., Gamil S., Zaher A.

    • Year: 2021

Conclusion:

Dr. Amal Zaher Shehata Mohamad exhibits all qualities worthy of the Best Researcher Award: an extensive and impactful publication record, demonstrated interdisciplinary collaboration, contribution to solving urgent environmental issues, and an ongoing commitment to scientific excellence.

Her body of work is not only significant in terms of innovation and academic depth but also reflects real-world applicability and societal relevance—key benchmarks for any researcher considered for high-level recognition. As such, she is eminently qualified and deserving of consideration for this prestigious honor.

Zhang Huilong | Plant Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Zhang Huilong | Plant Cell Biology | Best Researcher Award

Dr. Zhang Huilong, Institute of Ecological Conservation and Restoration, Chinese Academy of Forestry, China

Dr. Zhang Huilong is a dedicated plant scientist specializing in botany, currently serving as an Assistant Professor at the Institute of Ecological Conservation and Restoration, Chinese Academy of Forestry. His research primarily focuses on the physiological, biochemical, and molecular mechanisms underpinning salt and drought tolerance in woody halophytes, particularly in northern China. With a deep commitment to the improvement and innovation of saline-tolerant germplasm, he plays a pivotal role at the Research Center of Saline and Alkali Land of the National Forestry and Grassland Administration. Dr. Zhang has co-authored over 20 SCI-indexed publications, with 5 as a first or co-first author, amassing an impressive cumulative impact factor of 51. His work contributes significantly to ecological restoration, saline land utilization, and sustainable forestry, making him a strong candidate for the Best Researcher Award.

Publication Profile:

Orcid

🏆 Strengths for the Award:

  1. Robust Research Output

    • Published 20 SCI papers, including 5 as first/co-first author, with a cumulative impact factor of 51.

    • Focused research on Nitraria sibirica Pall., a halophyte of ecological and economic value in saline lands.

  2. Specialized Expertise

    • Deep specialization in molecular biology,plant physiology, and biochemistry, especially under salinity and drought stress.

  3. Applied Scientific Impact

    • Research contributes to germplasm innovation and genetic improvement of saline-tolerant woody plant aiding land restoration and sustainable forestry in northern China.

  4. Institutional Recognition

    • Holds a prestigious position as Assistant Professor at the Chinese Academy of Forestry, a national-level institute.

    • Affiliated with the Research Center of Saline and Alkali Land, a specialized unit under the National Forestry and Grassland Administration.

  5. Collaborative Science

    • Active collaborations reflected in multi-author publications, signaling team science and cross-disciplinary research.

🔧 Areas for Improvement:

  1. International Visibility

    • Could benefit from presenting at international conferences or joining global research networks on plant stress physiology or saline agriculture.

  2. Innovation Translation

    • Increase field-level trials and technology transfer of lab findings to practical applications in agriculture or ecological restoration.

  3. Leadership Development

    • Taking lead roles in international projects, editorial boards, or as principal investigator of global grants would elevate his profile further.

🎓 Education:

Dr. Zhang Huilong earned his Ph.D. in Botany with a specialization in plant molecular biology, biochemistry, and physiology. Throughout his academic training, he developed a strong foundation in plant stress biology, particularly focusing on mechanisms that confer salinity and drought tolerance. His doctoral research was rooted in exploring the genetic regulation and stress-response pathways in halophytes and woody plant species. He has continuously honed his expertise in cutting-edge methodologies including transcriptome analysis, gene overexpression systems, and physiological characterization under abiotic stress. His academic trajectory reflects a strong commitment to both fundamental and applied plant science, with the goal of developing resilient plant varieties for saline and arid ecosystems. His rigorous scientific training has enabled him to bridge molecular insights with practical breeding and conservation strategies aimed at improving land productivity under extreme environmental conditions.

💼 Work Experience:

Dr. Zhang Huilong currently holds the position of Assistant Professor at the Chinese Academy of Forestry, specifically within the Research Center of Saline and Alkali Land, under the National Forestry and Grassland Administration. In this role, he leads and collaborates on multidisciplinary research projects aimed at ecological conservation and restoration in saline-affected regions. He brings over a decade of experience in plant molecular biology, plant physiology, and stress tolerance research. His expertise spans functional genomics, salt-stress signaling networks, and genetic engineering for trait improvement in trees and halophytes. Dr. Zhang is actively engaged in mentoring young researchers, securing competitive research funding, and publishing in high-impact journals. He has also contributed significantly to the development of innovative technologies and strategies for afforestation and land reclamation in degraded ecosystems. His experience underscores his leadership in integrating basic research with real-world environmental solutions.

🔬 Research Focus:

Dr. Zhang Huilong’s research centers on understanding the molecular mechanisms that enable woody halophytes to tolerate abiotic stresses, particularly salinity and drought. His primary model plant is Nitraria sibirica Pall., a salt-tolerant shrub native to arid regions of China. His work integrates transcriptomics, gene family analyses, and functional studies to identify key genes—such as NsVP1 and NsSRO1a—that enhance tolerance in model plants like Arabidopsis. In addition, he investigates physiological responses, ion homeostasis (K⁺/Na⁺ regulation), and ROS signaling pathways under stress. He also works on the genetic improvement and germplasm innovation of saline-tolerant trees, aiming to restore and utilize marginal lands. His interdisciplinary approach bridges molecular biology with applied forestry, offering practical solutions for environmental challenges. Through impactful publications and pioneering research, Dr. Zhang is building a resilient plant platform to support sustainable forestry and land restoration under climate change.

📚 Publications Top Notes:

  1. 🌱 Overexpression of the Nitraria sibirica Pall. H⁺-pyrophosphatase gene NsVP1 improves Arabidopsis salt tolerance

  2. 🌵 Analysis of SRO gene family in Nitraria sibirica Pall. and the function of NsSRO1a in improving plant drought tolerance

  3. 🧬 Genome-Wide Identification of the 14-3-3 Gene Family and Its Involvement in Salt Stress Response through Interaction with NsVP1

  4. 🌿 Full-Length Transcriptome Analysis of the Halophyte Nitraria sibirica Pall.

  5. 🌳 Populus euphratica Phospholipase Dδ Increases Salt Tolerance by Regulating K⁺/Na⁺ and ROS Homeostasis in Arabidopsis

  6. 🍄 Ectomycorrhizal Fungal Strains Facilitate Cd²⁺ Enrichment in a Woody Hyperaccumulator under Cadmium and Salt Stress

  7. 💧 Populus euphratica Apyrases Increase Drought Tolerance by Modulating Stomatal Aperture in Arabidopsis

  8. 🧪 Tissue tolerance mechanisms conferring salinity tolerance in Nitraria sibirica Pall.

  9. 🌾 Antioxidant Enzymatic Activity and Osmotic Adjustment in Carex duriuscula under Drought Stress

  10. ⚡ A Salt-Signaling Network Involving Ethylene, ATP, H₂O₂, and Calcium Mediates K⁺/Na⁺ Homeostasis in Arabidopsis

✅ Conclusion:

Dr. Zhang Huilong exemplifies the core attributes of a Best Researcher Award recipient: scientific excellence, real-world impact, and dedication to solving environmental challenges. His focused work on salt- and drought-tolerant woody plants is not only scientifically innovative but also critical for addressing land degradation in arid and semi-arid zones of China. With an impressive track record, solid research foundation, and promising career trajectory, Dr. Zhang is a highly deserving nominee for this recognition

Frederick Silver | Cellular Mechanotransduction Pathways | Breakthrough Research Award

Published on by Cell Biologist

Prof. Frederick Silver | Cellular Mechanotransduction Pathways | Breakthrough Research Award 

Prof. Frederick Silver, Rutgers, the State University of New Jersey, United States

Dr. Frederick H. Silver is a distinguished Professor of Pathology and Laboratory Medicine at Rutgers University, with a research legacy spanning over four decades. He holds a Ph.D. in Polymer Science with a Biology minor from MIT and has served in prestigious roles at Harvard Medical School, Massachusetts General Hospital, and UMDNJ. Renowned for his pioneering work in collagen fibrillogenesis and biomedical engineering, Dr. Silver bridges polymer chemistry with clinical medicine. He has authored influential publications and contributed significantly to the development of optical diagnostic tools and implantable biomaterials. His work has led to notable advancements in tissue mechanics, mechanotransduction, and skin cancer detection using telemedicine. A dedicated educator and mentor, Dr. Silver’s interdisciplinary expertise continues to shape innovations in pathology, biomechanics, and biomedical imaging. His career reflects a strong commitment to translational science aimed at improving patient care through engineering-driven medical solutions.

publication profile :

Scopus

🧠 Strengths for the Award:

  1. Pioneering Research in Collagen Biomechanics
    Dr. Silver’s foundational work on collagen fibrillogenesis has advanced the understanding of tissue mechanics and biomaterials, making lasting contributions to regenerative medicine, biomimetics, and pathology.

  2. Innovations in Non-Invasive Diagnostics
    His leadership in developing Vibrational Optical Coherence Tomography (VOCT) for skin cancer detection demonstrates impactful innovation in telemedicine, aligning with modern healthcare needs.

  3. Multidisciplinary Expertise
    With dual foundations in engineering and biomedical sciences, Dr. Silver bridges disciplines to create integrative solutions—ideal for a breakthrough-level award.

  4. Sustained Research Excellence
    Over four decades of active research, including publications in high-impact journals, multiple collaborations, and over 20 peer-reviewed articles and reviews since 2023 alone, indicate a thriving and influential research program.

  5. International Recognition and Impact
    Recent recognitions like the 2024 Advanced Materials Scientist Award, 2025 Forensic Scientist Best Researcher Award, and top global rankings in collagen research (#17 by GPS Scholar) confirm his international influence.

🛠️ Areas for Improvement:

  1. Global Collaboration Expansion
    While his publication and innovation record is strong, expanding international collaborations or participation in global consortia could further amplify the reach and scalability of his innovations.

  2. Commercial Translation
    His technologies, especially VOCT, show high potential for real-world application. Increased emphasis on commercialization, clinical trials, or startup development could broaden their societal impact.

  3. Diversity of Research Funding
    While his early funding from NIH and NSF is commendable, acquiring current or recent large-scale multidisciplinary grants could further support the breakthrough narrative.

🎓 Education :

Dr. Silver’s academic journey began with a B.S. in Chemical Engineering from Northeastern University in 1972. He advanced to the Massachusetts Institute of Technology (MIT), where he earned an S.M. in Textile Technology in 1975 and a Ph.D. in Polymer Science in 1977, with a minor in Biology. His doctoral work at MIT laid the foundation for his lifelong research into collagen biochemistry, biomechanics, and polymer-tissue interactions. Combining engineering principles with biomedical applications, his education was multidisciplinary and forward-looking—integrating materials science, biochemistry, and physiology. His academic training positioned him as a pioneer in biomedical engineering before the field gained widespread recognition. This fusion of chemical, biological, and material sciences remains central to his scientific contributions, enabling him to design biomimetic materials and study tissue behavior under mechanical forces, ultimately contributing to novel diagnostics and implants.

💼 Experience :

Dr. Silver began his academic career as a Research Fellow at Massachusetts General Hospital (1977–1979), where he later became Director of the Physical Biochemistry Laboratory. Simultaneously, he served as an Instructor and then Assistant Professor of Pathology at Harvard Medical School. He also held an adjunct professorship at Boston University in Biomedical Engineering. In 1981, he joined the faculty at UMDNJ-Robert Wood Johnson Medical School, becoming a tenured Associate Professor. He is a long-standing member of the graduate faculty in Biomedical Engineering at Rutgers. With roles spanning academic medicine, biochemistry labs, and engineering faculties, Dr. Silver has mentored students across disciplines while pursuing cutting-edge research in tissue mechanics, collagen assembly, and optical diagnostics. His career exemplifies cross-disciplinary collaboration, with leadership positions that influence both research and clinical practice. His blend of teaching, research, and clinical translation has made him a central figure in pathology and biomedical engineering.

🏆 Awards and Honors :

Dr. Frederick H. Silver has received several prestigious honors recognizing his influential career in biomedical science. In 2024, he was named an International Association of Advanced Materials Scientist (Metal Category), highlighting his materials science innovations. He was also ranked #17 globally for Lifetime Collagen Research by GPS Scholar, reflecting his enduring impact on connective tissue studies. In 2025, he earned the Best Researcher Award in Forensic Science, acknowledging his work’s relevance in medical diagnostics and legal pathology. These honors underscore a research career marked by interdisciplinary innovation and global recognition. His early work was supported by national grants from the NIH and NSF, beginning with a National Research Service Award in 1977. These awards and continued scholarly achievements show a career dedicated to advancing medical science through novel materials, mechanobiology, and non-invasive diagnostics—establishing him as a role model in translational research and interdisciplinary leadership.

🔬 Research Focus :

Dr. Silver’s research centers on the mechanical and structural properties of connective tissues, with a focus on collagen fibrillogenesis, biomechanics, and tissue-engineered implants. He explores how energy dynamics influence mechanotransduction in both normal and cancerous tissues. A major thrust of his current research is in the development of Vibrational Optical Coherence Tomography (VOCT)—a non-invasive diagnostic tool used for detecting skin cancers and assessing tissue stiffness. He also investigates ocular biomechanics, including corneal elasticity and viscoelastic properties. Dr. Silver’s interdisciplinary approach combines polymer science, biophysics, and clinical pathology to design biomaterials and imaging techniques that emulate natural tissue behavior. His research not only advances basic science but also has direct applications in telemedicine, wound healing, cancer diagnosis, and implant design. He continues to push the boundaries of translational medicine by integrating mechanical analysis, tissue biology, and material engineering into clinical solutions.

📚 Publications Top Notes:

  1. 📘 Thromboresistant Analogs of Vascular Tissue – Polymer Preprints, 1975

  2. 🧪 Glycosaminoglycan Inhibition of Collagen Induced Platelet Aggregation – Thrombosis Research, 1978

  3. 🩸 In Vitro Blood Compatibility of Glycosaminoglycan Precipitated Collagens – J. Biomed. Mater. Res., 1979

  4. 🔬 Type I Collagen Fibrillogenesis: Initiation Via Reversible Growth Steps – Biopolymers, 1979

  5. 📈 Linear Aggregation and Lag Phase in Collagen Fibrillogenesis – J. Theor. Biol., 1979

  6. 🧬 Type I Collagen Structure in Solution and Fibril Fragments – J. Biol. Chem., 1980

  7. 🐣 Type V Collagen from Chick Embryo: Structural Characteristics – Collagen Related Res., 1981

  8. 💧 Physical Properties of Type I Collagen in Solution – Biopolymers, 1981

  9. 🧩 Collagen Fibrillogenesis: Assembly Mechanism – J. Biol. Chem., 1981

  10. 🛢️ Molecular Structure of LGP-I in Cartilage Lubrication – J. Biol. Chem., 1981

✅ Conclusion:

Dr. Frederick H. Silver is highly suitable for the Breakthrough Research Award. His long-standing leadership in collagen research, mechanical biology, and optical diagnostic development has positioned him at the forefront of translational biomedical innovation. His contributions go beyond academic discovery—they offer real-world healthcare solutions, especially in cancer diagnostics and tissue engineering. His work exemplifies the spirit of breakthrough research, combining deep foundational science with high-impact application. With minor enhancements in global collaboration and translational visibility, Dr. Silver’s profile would be nearly unmatched in its breadth and relevance.

Yan Jiao | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Yan Jiao | Cancer Cell Biology | Best Researcher Award

Dr. Yan Jiao, First Hospital of Jilin University, China

Dr. Yan Jiao is an accomplished Attending Physician and clinical researcher at the First Hospital of Jilin University, specializing in hepatobiliary and pancreatic diseases. With dual degrees—a Bachelor of Medicine and a Ph.D. from Jilin University—Dr. Jiao has combined clinical acumen with deep expertise in bioinformatics and statistical analysis. A prolific researcher, Dr. Jiao has published extensively on topics ranging from liver cancer and immunotherapy to the adverse effects of diagnostic dyes and post-surgical complications. Notably, Dr. Jiao has contributed to scientific integrity through independent verification of published data and has reported anomalies that led to editorial actions. Skilled in R programming and mining public health datasets, Dr. Jiao blends analytical precision with a commitment to improving patient outcomes. Recognized for a meticulous approach to research, Dr. Jiao’s work exemplifies scientific rigor and ethical responsibility, making a compelling case for the Best Researcher Award.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Outstanding Publication Record:
    Dr. Jiao has co-authored over 20 peer-reviewed journal articles in high-impact journals like Scientific Reports, International Journal of Nanomedicine, and World Journal of Gastrointestinal Surgery. The research spans critical fields like liver cancer, gastric cancer, bioinformatics, and surgical safety, demonstrating multidisciplinary excellence.

  2. High Ethical Standards:
    A rare and commendable contribution is Dr. Jiao’s work in scientific integrity—verifying published studies, detecting image manipulation, and triggering investigations into misconduct. This highlights not only academic rigor but also moral responsibility in research.

  3. Bioinformatics Expertise:
    Proficient in R programming and analysis of large public datasets (FAERS, NHANES, TCGA), Dr. Jiao merges clinical insight with data science to generate real-world impact. The capacity to handle complex data with statistical precision is vital in modern medical research.

  4. Clinical & Research Integration:
    As a practicing Attending Physician in hepatobiliary and pancreatic diseases, Dr. Jiao directly applies research outcomes to clinical settings. This dual competency strengthens translational research and improves patient-centered outcomes.

  5. Collaborative Network:
    Dr. Jiao has worked with a wide range of co-authors, showing adaptability and a collaborative spirit. This not only strengthens individual studies but also reflects influence within a broader research community.

🛠️ Areas for Improvement:

  1. Global Research Visibility:
    While Dr. Jiao has a strong publication portfolio, more engagement with global conferences, keynote presentations, and international collaborations would enhance international recognition.

  2. Grant Leadership:
    There is limited information on independent research funding or grant leadership. Applying for and leading funded projects could further establish Dr. Jiao’s credentials as a principal investigator.

  3. First-Author Publications:
    Though a frequent contributor, a higher proportion of first-author or corresponding-author roles would solidify recognition as a lead researcher, particularly in high-impact original studies.

🎓 Education:

Dr. Yan Jiao pursued both undergraduate and doctoral studies at Jilin University, one of China’s top research institutions. From 2011 to 2016, Dr. Jiao earned a Bachelor of Medicine, laying the groundwork in clinical sciences and human biology. Continuing seamlessly into advanced research, Dr. Jiao completed a Ph.D. at the same university from 2016 to 2019, with a focus on hepatobiliary diseases and translational bioinformatics. The doctoral training combined clinical exposure with robust coursework in molecular biology, epidemiology, and data science. This dual qualification reflects a rare integration of frontline medical experience and deep academic inquiry, preparing Dr. Jiao for a career at the intersection of medicine, research, and technological innovation. Throughout academic training, Dr. Jiao demonstrated a strong aptitude for evidence-based medicine and statistical modeling, gaining recognition for a disciplined and inquisitive approach. The education path reflects a trajectory of consistent excellence and interdisciplinary competence.

💼 Professional Experience:

Dr. Yan Jiao currently serves as an Attending Physician at the First Hospital of Jilin University, where the clinical focus lies in hepatobiliary and pancreatic diseases. In this role, Dr. Jiao combines patient care with research initiatives, particularly in liver cancer. Beyond clinical duties, Dr. Jiao is actively engaged in bioinformatics research, utilizing datasets like FAERS, TCGA, and NHANES to uncover patterns in disease and treatment outcomes. With expert-level proficiency in R programming, Dr. Jiao conducts complex statistical analyses and visualizations. A distinct part of Dr. Jiao’s experience involves auditing the scientific literature for data anomalies and image manipulation, contributing anonymously to investigations into research misconduct. This dual role as a clinician and data scientist uniquely positions Dr. Jiao to address both practical and theoretical challenges in healthcare. Dr. Jiao’s professional journey underscores a rare blend of technical skills, ethical vigilance, and medical expertise, reinforcing eligibility for prestigious research awards.

🔬 Research Focus:

Dr. Yan Jiao’s research is deeply rooted in hepatobiliary oncology, with a specific focus on liver cancer diagnosis, treatment strategies, and prognosis modeling. Integrating clinical insights with computational analysis, Dr. Jiao utilizes large public datasets like TCGA, FAERS, and NHANES to examine treatment efficacy, drug safety, and genetic risk factors. A significant thrust of the research lies in immunotherapy, chemoembolization techniques, and the safety of diagnostic agents like Indocyanine Green. Dr. Jiao also explores post-operative complications and gastrointestinal disorders, broadening the scope of clinical relevance. Equally important is the investigation into scientific integrity, where Dr. Jiao’s efforts in identifying manipulated data and statistical inconsistencies have led to editorial scrutiny in major journals. By bridging bioinformatics with hands-on medical practice, the research offers both theoretical advancements and actionable clinical solutions. Dr. Jiao’s focus is future-facing, centered on personalized treatment and real-world data analysis to optimize patient outcomes.

📚 Publications Top Notes:

  1. 📉 Obesity-Surgery is not the end.

  2. 💉 Landscape of transarterial chemoembolization for hepatocellular carcinoma.

  3. 🧬 Immunotherapy for metastatic gastric cancer.

  4. ⚠️ Exploring the dark side of diagnostic dyes – Indocyanine green.

  5. 🧬 Long non-coding RNA HOTAIR in liver cancer cell behavior.

  6. 🧪 Abraxane-related adverse events – FAERS decade-long analysis.

  7. 🧬 Personalized treatment of perihilar cholangiocarcinoma.

  8. 💊 Impact of immunotherapy on liver metastasis.

  9. 🏥 Incisional hernia after laparoscopic colorectal surgery.

  10. 🔍 Intestinal Behçet’s disease: Diagnosis and treatment.

🧾 Conclusion:

Dr. Yan Jiao is a highly qualified and deserving candidate for the Best Researcher Award. With an exceptional combination of clinical experience, research productivity, ethical vigilance, and bioinformatics expertise, Dr. Jiao stands out as a well-rounded and impactful medical scientist. While there is room to further elevate global visibility and leadership in grant-funded research, the current portfolio already reflects excellence in translational science and data-driven healthcare. In conclusion, Dr. Jiao’s contributions are not only prolific but principled—making this nomination both timely and justified.

baofeng wang | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. baofeng wang | Cancer Cell Biology | Best Researcher Award

Prof. baofeng wang, Department of Radiation Therapy, Second Affiliated Hospital of Medical School, Xi’an Jiaotong University, Xi’an 710004, China, China

Dr. Baofeng Wang is a Professor and Associate Chief Physician at The Second Affiliated Hospital of Xi’an Jiaotong University. He serves as Head of the Abdominal Oncology Group in the Department of Radiation Oncology and is a Master’s Supervisor. Renowned for his expertise in abdominal and liver cancers, Dr. Wang actively contributes to several professional organizations, including the Chinese Society for Radiation Oncology (CSRO). As a reviewer for top journals and a recipient of multiple prestigious research awards, his work integrates clinical excellence with cutting-edge research. He has led three national and provincial-level projects and has authored over 40 scientific articles, with more than 10 published in SCI-indexed journals. His recent work focuses on ferroptosis, immune regulation in cancer, and BNCT treatment planning, marking him as a leading figure in translational oncology research.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Academic and Clinical Leadership:

    • Professor, Associate Chief Physician, and Master’s Supervisor.

    • Head of the Abdominal Oncology Group at a leading national medical institution.

    • Actively leads and shapes treatment protocols in radiation oncology.

  2. Research Productivity and Impact:

    • Authored over 40 scientific publications, with more than 10 indexed in SCI journals.

    • Principal Investigator for 3 major funded research projects.

    • Co-investigator in 5 additional national and provincial projects.

    • Reviewer for high-impact international journals, ensuring scientific rigor in oncology research.

  3. Recognition and Awards:

    • Winner of two First Prizes for Scientific and Technological Progress in Higher Education Institutions.

    • Received a Second Prize from the Shaanxi Provincial Scientific and Technological Progress Awards.

  4. Professional Influence:

    • Holds multiple key positions in national and provincial medical societies, especially within the Chinese Society for Radiation Oncology (CSRO).

    • Active in bridging research, clinical practice, and public health education.

  5. Recent Research Focus:

    • Investigating mechanisms of radioresistance via ferroptosis and cholesterol metabolism.

    • Advancing boron neutron capture therapy (BNCT) planning and immunoregulatory pathways in breast cancer and hepatocellular carcinoma.

⚙️ Areas for Improvement:

  1. Global Collaboration:

    • While domestically influential, expanding international collaborations and partnerships could further elevate the research impact and visibility.

  2. Citation Index and Research Translation:

    • Despite a good number of publications, a higher citation count and more translational outcomes into clinical practice would strengthen the award candidacy further.

  3. Innovation Leadership:

    • Developing patents or pioneering novel therapeutic technologies would add to innovation metrics.

🎓 Education:

Dr. Baofeng Wang received rigorous academic training in the medical sciences, specializing in oncology and radiation therapy. After completing his undergraduate medical degree, he pursued postgraduate studies focused on radiation oncology and tumor biology. His advanced academic pursuits led to a comprehensive understanding of radiobiology, imaging-guided radiotherapy, and molecular oncology. He continuously updates his knowledge through professional development programs and has contributed to both educational and research domains by mentoring postgraduate students. His commitment to academic excellence is evident through his role as a Master’s Supervisor, guiding the next generation of clinical researchers. Dr. Wang’s educational background has equipped him with the skills necessary to integrate evidence-based medicine with innovative research, particularly in the fields of liver cancer and immuno-oncology.

🧪 Professional Experience:

With over 15 years of clinical and academic experience, Dr. Baofeng Wang is a leading figure in the field of radiation oncology. Currently a Professor and Associate Chief Physician, he heads the Abdominal Oncology Group at The Second Affiliated Hospital of Xi’an Jiaotong University. He has been instrumental in developing individualized radiotherapy protocols for complex tumors. His leadership roles in various national and provincial oncology organizations highlight his influence in shaping cancer treatment strategies. He has served as Principal Investigator for several research grants from the National Natural Science Foundation of China and provincial R&D bodies. Additionally, Dr. Wang plays an active role in academic peer review and science promotion in Shaanxi province. His blend of clinical acumen and research proficiency makes him a cornerstone in the advancement of radiotherapy techniques and translational oncology.

🔬 Research Focus:

Dr. Wang’s research focuses on the intersection of radiation oncology, tumor metabolism, and immunoregulation. He investigates how cellular mechanisms such as ferroptosis and cytokine modulation contribute to radioresistance and tumor progression. A major area of interest is the optimization of boron neutron capture therapy (BNCT) treatment planning, aiming to enhance therapeutic outcomes in abdominal cancers. His work also explores the role of tumor-infiltrating immune cells and how factors like interleukin-10 influence immune suppression and therapy response. By integrating molecular diagnostics with imaging-guided radiotherapy, Dr. Wang seeks to improve precision medicine strategies. His translational research aims to convert lab-based discoveries into clinically viable cancer treatments, particularly for liver, breast, and gastrointestinal cancers. Through collaborative and interdisciplinary research, Dr. Wang’s work continues to push boundaries in oncology innovation.

📚 Publications Top Notes:

  1. 🧬 Recent research progress of BNCT treatment planning system

  2. 🔗 SCARB1 links cholesterol metabolism-mediated ferroptosis inhibition to radioresistance in tumor cells

  3. 🎯 BAFF overexpression in triple-negative breast cancer promotes tumor growth by inducing IL-10-secreting regulatory B cells that suppress anti-tumor T cell responses

  4. 🛡️ Interleukin-10 overexpression in 4T1 cells: A gateway to suppressing mammary carcinoma growth

📌 Conclusion:

Dr. Baofeng Wang exemplifies the qualities of an exceptional clinical researcher, balancing leadership, clinical service, and impactful research. His contributions to radiation oncology—particularly in abdominal and liver cancers—along with national-level recognition and funding, make him a highly suitable and competitive candidate for the Best Researcher Award. Continued expansion of his international footprint and translational outputs would position him even more prominently on the global stage.

Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Prof. Dr. Sibel Elif Gultekin, Gazi University Faculty of Dentistry, Turkey

Prof. Dr. Sibel Elif Gültekin is a renowned academic and clinician in Oral Pathology and Periodontology at Gazi University Faculty of Dentistry, Türkiye. With over two decades of experience, she has significantly advanced molecular understanding of odontogenic tumors, HPV-induced oral lesions, and periodontal regeneration. Holding both DDS and Ph.D. degrees, she has led her department as Chair for 10 years and contributed globally as a visiting researcher and advisor. Her collaborations with institutions like the University of Cologne and UCSF reflect her international impact. She has published extensively in high-impact journals, authored books, and mentored numerous young researchers. Her dedication has been recognized through editorial appointments and professional society memberships. Prof. Gültekin’s translational research bridges pathology and clinical dentistry, making her a pioneer in the diagnosis and treatment of oral diseases.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Dual Specialization & Academic Leadership: Prof. Gültekin’s rare dual Ph.D. in Oral Pathology and Periodontology, along with her decade-long leadership as department chair, highlights deep academic and organizational expertise.

  2. High Research Output & Impact: With 96 publications, 50+ research projects, and citations exceeding 1300 (Google Scholar), her scholarly productivity and influence are clear. Her h-index across databases (14–17) confirms consistent academic contribution.

  3. Global Collaborations: Active collaborations with international centers like UCSF and University of Cologne underscore her role in global scientific advancement.

  4. Innovative Research Areas: She works at the forefront of molecular oncology, focusing on HPV-associated oral cancers, odontogenic tumors, and biomarkers like P16, VIM3, and PDCD4.

  5. Educational & Editorial Leadership: Served on scientific and editorial boards, symposiums, and advisory panels; she also authored 2 academic books and guided national congresses.

  6. Professional Societies: Active member of multiple esteemed societies (IAOP, ESP, EHNS, IADR), reflecting recognition in the international scientific community.

⚙️ Areas for Improvement:

  1. Clinical Translation Scaling: While her biomarker discoveries are notable, increasing efforts to lead translational clinical trials could accelerate therapeutic application.

  2. Policy Advocacy: Engaging more in international oral health policy or WHO-affiliated programs could amplify her impact beyond academia.

  3. Mentorship on Global Scale: Expanding formal international mentorship programs or fellowships could further cement her influence and legacy.

🎓 Education:

Prof. Dr. Sibel Elif Gültekin holds both DDS and Ph.D. degrees, specializing in Oral Pathology and Periodontology. She completed her undergraduate dental studies at Gazi University Faculty of Dentistry, where she later pursued her doctoral studies. Her academic training extended beyond Türkiye through international fellowships and research placements, including the prestigious Department of Medicine and Stomatology at the University of California San Francisco (UCSF) and the Institute for Pathology at the University of Cologne. Her educational journey is marked by an interdisciplinary approach, blending basic sciences and clinical applications. These robust academic foundations have positioned her as a global expert in oral cancer biomarkers, regenerative periodontology, and molecular pathology, nurturing future dentists and researchers through an integrative, evidence-based curriculum and global research exposure.

💼 Experience:

Prof. Dr. Gültekin has over 25 years of experience in dentistry, oral pathology, and periodontology. She has served as Professor and Chair of the Department of Oral Pathology at Gazi University, shaping both academic curricula and national diagnostic standards. Internationally, she collaborated with UCSF and the University of Cologne on pioneering projects in oral cancer and HPV research. Her clinical and academic background spans over 50 funded research projects, with 96 published papers in prestigious journals indexed by SCI, Scopus, and PubMed. She has contributed to oral health policy through editorial and advisory roles, including at journals like Journal of Oral Health Frontiers. Her expertise has guided scientific boards and symposia in Türkiye and beyond, particularly in head and neck pathology. She remains a sought-after consultant and reviewer, advocating for personalized medicine and molecular diagnostics in oral health.

🔬 Research Focus:

Prof. Dr. Sibel Elif Gültekin’s research centers on the molecular mechanisms of oral diseases, particularly odontogenic tumors, oral epithelial dysplasia, and HPV-induced carcinomas. She has made key contributions in identifying biomarkers such as P16, PDCD4, VIM3, and CD8+ T-cell infiltrates, enhancing early diagnosis and prognosis of oral and oropharyngeal cancers. Her research also explores microsatellite instability and loss of heterozygosity in oral squamous cell carcinoma. Additionally, she has contributed to periodontal tissue regeneration studies and the development of personalized therapeutic strategies. With over 1,300 citations and an h-index of 17 on Google Scholar, her impactful work bridges molecular science and clinical application. Collaborating with global experts in pathology, oncology, and molecular biology, Prof. Gültekin’s research not only contributes to academic literature but also informs clinical protocols and treatment pathways in modern dentistry and oral oncology.

📚 Publications Top Notes:

  • 🧬 Microsatellite Instability and Loss of Heterozygosity as Prognostic Markers in Oral Squamous Cell Carcinoma (Genes, Chromosomes and Cancer, 2024)

  • 🧪 Efficiency of B-RAF-/MEK-inhibitors in B-RAF Mutated Ameloblastoma: Case Report and Review (Heliyon, 2023)

  • 🦷 Kişiselleştirilmiş Diş Hekimliği (ADO Klinik Bilimler Dergisi, 2023)

  • 🔍 Apoptosis Related PDCD4: Promising Novel Biomarker for Early Detection of Oral Cancer (ADO Klinik Bilimler Dergisi, 2022)

  • 🛡️ PD-L1 Expression and High CD8+ Lymphocyte Infiltrate Predict Outcome in Oropharyngeal SCC (International Journal of Molecular Sciences, 2020)

🧾 Conclusion:

Prof. Dr. Sibel Elif Gültekin is a highly deserving nominee for the Best Researcher Award. Her pioneering contributions in oral pathology, particularly in molecular diagnostics and HPV-related oral oncology, place her at the forefront of dental research. Her exceptional academic record, leadership, and dedication to collaborative and translational science make her a standout candidate who embodies the spirit of innovation, mentorship, and global impact.

Dalia Saleh | Cancer Cell Biology | Innovative Research Award

Published on by Cell Biologist

Prof. Dalia Saleh | Cancer Cell Biology | Innovative Research Award

Prof. Dalia Saleh, National Research Centre, Egypt

Dr. Dalia Osama Abd El Fattah Saleh is a distinguished pharmacologist and professor at the National Research Centre, Cairo, Egypt. With a career spanning over two decades in academic and pharmaceutical research, she specializes in molecular pharmacology, experimental therapeutics, and drug development. She earned her Ph.D. and M.Sc. in Pharmacology from Cairo University, where she also completed her undergraduate pharmacy degree with honors. Dr. Saleh’s prolific contributions to science are reflected in her extensive publication record, focusing on novel therapeutic strategies against various toxicological, metabolic, and inflammatory disorders. Her collaborative efforts have led to advancements in drug signaling pathways, phytochemical pharmacology, and nanotechnology-based delivery systems. Recognized nationally for her innovation, she has received several prestigious awards. Dr. Saleh continues to shape pharmacological research through her dedication to translational science, mentorship, and participation in international seminars and training programs.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  • Extensive Academic Background: Holds a Ph.D., M.Sc., and B.Sc. in Pharmacology from Cairo University, with a clear focus on endocrine and vascular pharmacology from early in her career.

  • Distinguished Research Record: Authored over 25+ high-impact publications in peer-reviewed journals including Scientific Reports, Toxicology Reports, Biochemistry and Cell Biology, and Environmental Science and Pollution Research.

  • Novel Scientific Contributions:

    • Explores molecular pharmacology through cutting-edge therapeutic approaches like AMPK/mTOR signaling, Nrf2/NF-κB modulation, and natural compound pharmacodynamics.

    • Studies involve both synthetic and phytochemical-based interventions, representing a hybrid and innovative research style.

  • Awards and Recognition:

    • National recognition for her research quality and productivity by the National Research Centre, with awards received in 2015 and 2020.

    • Ranked 24th in the institution for publication volume in 2014—an indicator of sustained output.

  • Global Exposure: Participated in professional training programs at King’s College London, enhancing her knowledge in clinical drug development and data management—an asset for interdisciplinary and translational research.

  • Leadership and Longevity: Promoted through all academic ranks at NRC, from Research Assistant to Professor, demonstrating not only competence but leadership and mentorship over time.

Areas for Improvement:

  • Clinical Translation: While the preclinical research is extensive, initiating clinical trials or translational studies would further strengthen the real-world applicability of her findings.

  • Global Visibility: Although trained internationally, more international speaking engagements, keynote invitations, or editorial roles could enhance global recognition.

  • Interdisciplinary Projects: Expanding collaborations across fields such as bioinformatics or biotechnology could amplify the innovation aspect of her work.

🎓 Education:

Dr. Dalia Saleh obtained all her academic degrees from Cairo University’s esteemed Faculty of Pharmacy. She was awarded her Ph.D. in Pharmacology in 2012 for her thesis examining estrogen’s vascular effects in insulin-resistant, ovariectomized rats. Earlier, she earned her M.Sc. in 2009 with research on rosiglitazone’s effects in streptozotocin-induced vascular changes. Her academic journey began with a B.Sc. in Pharmacy in 2002, graduating with distinction and honors. Her strong educational foundation laid the groundwork for her innovative and interdisciplinary research spanning molecular pharmacology, toxicology, and metabolic disorders. Through continuous professional development, including modules at King’s College London, Dr. Saleh stays aligned with global standards in pharmacological science and clinical drug development. Her educational background combines academic excellence with practical research expertise, making her well-equipped to address complex biomedical challenges.

👩‍🔬 Experience:

Dr. Dalia Saleh has built a progressive research career at Egypt’s National Research Centre, beginning as a Research Assistant in 2003. Over the years, she rose through the ranks to become a Professor in 2022. She previously held positions as Researcher (2012–2017) and Assistant Professor (2017–2022). Throughout her tenure, she has actively contributed to preclinical pharmacology research, focusing on inflammation, neuroprotection, metabolic diseases, and organ toxicity. Her interdisciplinary approach integrates pharmacodynamics, molecular signaling, and therapeutic intervention studies using both synthetic and natural compounds. She has led numerous studies that explore drug mechanisms at cellular and systemic levels, often employing rodent disease models. Dr. Saleh’s active participation in international training (e.g., at King’s College London) highlights her global engagement and commitment to continuous learning. Her career reflects not only research productivity but also leadership in collaborative scientific initiatives and mentoring of emerging researchers.

🏆 Awards & Honors:

Dr. Dalia Saleh has received multiple accolades that underscore her impact in the field of pharmacology. She was honored with the 2020 Scientific Pioneers Award and the 2015 Scientific Encouragement Award from Egypt’s National Research Centre (NRC), recognizing her outstanding research contributions. In 2014, she received institutional recognition for both her high publication output (ranked 24th NRC-wide) and for publishing in a high-impact journal (impact factor 4.067). These achievements highlight her consistent scientific productivity and influence in biomedical research. Dr. Saleh’s awards reflect a career driven by innovation, rigor, and dedication to solving pressing health issues. Her work continues to be widely cited and applied in translational pharmacology, securing her reputation as a leading figure in her discipline. She remains an inspiration to peers and students alike, with a legacy of both scientific excellence and mentorship.

🔬 Research Focus:

Dr. Dalia Saleh’s research is rooted in experimental pharmacology, with an emphasis on cell signaling pathways, drug discovery, and natural compound pharmacodynamics. She investigates molecular mechanisms underlying chronic diseases such as diabetes, hepatic and renal injury, neurodegeneration, and inflammatory disorders. A recurring theme in her work is the modulation of key signaling axes (e.g., AMPK/mTOR, NF-κB, PI3K/Akt) in mitigating organ toxicity and disease progression. Her recent studies explore the pharmacological potential of phytochemicals, drug hybrids, and nanoformulations in preclinical models. Dr. Saleh also examines gender-specific pathophysiology, as seen in her Ph.D. research on estrogen’s role in vascular dysfunction. She actively integrates biochemical, histological, and behavioral endpoints to ensure translational relevance. By bridging traditional medicine and molecular pharmacology, her work contributes to next-generation therapeutics and precision medicine. Her research has both national and global impact, frequently published in high-tier journals and cited in clinical research discussions.

📚 Publications Top Notes:

  1. 🧬 Eugenol alleviates acrylamide-induced testicular toxicity via AMPK/pAKT/mTOR signaling – Scientific Reports, 2024

  2. 💊 Trimetazidine protects against cisplatin-induced neuropathy via AMPK and Nrf2 pathways – Biochemistry and Cell Biology, 2023

  3. 🧪 Chromone-thiazolopyrimidine hybrids inhibit TNF-α, IL-6, and PGE2 – Polycyclic Aromatic Compounds, 2023

  4. 🧻 Chrysin counters cyclophosphamide-induced cystitis via STAT-3 and NF-κB inhibition – Chemico-Biological Interactions, 2023

  5. 🩺 Linagliptin and L-arginine synergize in hyperacidity via EP4 upregulation – Naunyn-Schmiedeberg’s Archives of Pharmacology, 2023

  6. 🧠 L-arginine protects against hepatic encephalopathy via anti-apoptotic mechanisms – Environmental Science and Pollution Research, 2023

  7. 🌿 Calotropis procera seed oil shows anti-inflammatory and antiparasitic activity – Arabian Journal of Chemistry, 2022

  8. 🧫 Olmesartan mitigates diabetic nephropathy through TLR4/P38-MAPK modulation – European Journal of Pharmacology, 2022

  9. 🌱 Anti-fibrotic activities of Plumbago species in liver fibrosis models – Scientific Reports, 2022

  10. 🐟 Omega-3 fatty acids protect against doxorubicin-induced liver damage – Saudi Journal of Biological Sciences, 2022

Conclusion:

Dr. Dalia O. Saleh is highly suitable for the Best Researcher Award based on her prolific scientific contributions, consistent academic progression, and commitment to impactful pharmacological research. Her strength lies in combining rigorous mechanistic studies with applied therapeutic exploration, especially in inflammation, oxidative stress, and natural product pharmacology.